p53-Luc/EF1α-mCherry Reporter Cell Line - HepG2

HepG2 is a well-established human hepatocellular carcinoma cell line, widely recognized for its retention of various liver-specific metabolic functions and its epithelial-like morphology. The p53-Luc/EF1α-mCherry Reporter Cell Line - HepG2 is a specialized, dual-reporter engineered derivative designed to provide a sensitive, quantitative readout of p53 transcriptional activity. In this system, the Firefly luciferase gene is placed under the control of a p53 response element, while a red fluorescent protein (mCherry) is constitutively expressed under the EF1α promoter. Since HepG2 cells naturally harbor wild-type p53, this model is particularly robust for studying endogenous signaling. The luciferase signal acts as a dynamic indicator of p53 activation, whereas the mCherry signal functions as a built-in internal control, allowing for normalization against cell number and providing a stable marker for fluorescence-based assays or live-cell tracking.

This reporter line is primarily employed in drug discovery and toxicology to identify compounds that trigger the p53-mediated stress response. It is an ideal platform for high-throughput screening of potential anti-cancer agents, including DNA-damaging drugs or inhibitors of the MDM2-p53 interaction. Because the system includes a constitutive mCherry marker, researchers can easily distinguish between specific pathway activation and non-specific effects related to cell death, improving the accuracy of genotoxicity assessments. The line is also utilized in environmental science to evaluate the impact of chemical pollutants on DNA integrity within human liver cells. Its stable expression profile makes it suitable for long-term studies and complex experimental setups, such as 3D culture models or co-culture systems, where monitoring tumor suppressor dynamics in real-time is essential for understanding the molecular mechanisms of liver injury and repair.